ATX-GD-59 1.6 mg

Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
Image Checkout
Guaranteed Checkout
Want a discount? Become a member!

Introducing ATX-GD-59, a cutting-edge peptide-based therapy meticulously crafted for the management of Graves’ disease. With a molecular weight of 2529.26 and a molecular formula of C114H198N32O32, ATX-GD-59 surpasses research-grade benchmarks, highlighting our unwavering dedication to excellence and pioneering advancements.

ATX-GD-59 redefines medical paradigms through its innovative mode of action, engineered to emulate epitopes and effectively immobilize the leukocytes responsible for assaulting the thyroid. It obstructs the generation of anti-thyroid stimulating hormone receptor (TSHR) stimulatory antibodies, revolutionizing the approach beyond conventional treatments. This advanced strategy homes in on the immunological foundation of Graves’ disease, marking a transformative path in disease management brought forth by ATX-GD-59.